Companies Increase Adoption of Veeva Vault CTMS to Streamline Clinical Processes and html, body, #partner, iframe { Improve Visibility Across Studies
Tuesday, 03 October 2017 01:06
Oct. 3, 2017 11:03 UTC

Companies Increase Adoption of Veeva Vault CTMS to Streamline Clinical Processes and Improve Visibility Across Studies

More life sciences companies are bringing together clinical processes and information to streamline trial management

PHILADELPHIA--(BUSINESS WIRE)-- 2017 Veeva Global R&D Summit—Veeva Systems (NYSE:VEEV) announced that Veeva Vault CTMS is gaining momentum with global biopharmaceutical companies and clinical research organizations. In six months since the product’s availability, Veeva has added nine Vault CTMS customers, with two already live and using the product. Vault CTMS is the only modern cloud application that makes it easy for life sciences companies to unify clinical information and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

1 Veeva 2017 Unified Clinical Operations Survey: Annual CRO Report, September 6, 2017
2 Veeva 2017 Unified Clinical Operations Survey, June 19, 2017

Contacts

Veeva Systems
Roger Villareal, 925-264-8885
roger.villareal@veeva.com
or
Lisa Barbadora, 610-420-3413
pr@veeva.com


Source: Veeva Systems Inc.




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 
BMR:1